Astrana Health EBITDA Margin 2016-2026 | ASTH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Astrana Health (ASTH) over the last 10 years. The current EBITDA margin for Astrana Health as of March 31, 2026 is .
| Astrana Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-12-31 | $3.18B | $0.13B | 4.02% |
| 2025-09-30 | $2.90B | $0.10B | 3.49% |
| 2025-06-30 | $2.42B | $0.10B | 4.18% |
| 2025-03-31 | $2.25B | $0.11B | 4.93% |
| 2024-12-31 | $2.03B | $0.12B | 5.85% |
| 2024-09-30 | $1.72B | $0.11B | 6.45% |
| 2024-06-30 | $1.59B | $0.12B | 7.48% |
| 2024-03-31 | $1.45B | $0.11B | 7.78% |
| 2023-12-31 | $1.39B | $0.10B | 7.50% |
| 2023-09-30 | $1.33B | $0.12B | 9.04% |
| 2023-06-30 | $1.30B | $0.13B | 10.11% |
| 2023-03-31 | $1.22B | $0.12B | 9.77% |
| 2022-12-31 | $1.14B | $0.12B | 10.75% |
| 2022-09-30 | $1.05B | $0.11B | 10.81% |
| 2022-06-30 | $0.96B | $0.12B | 12.15% |
| 2022-03-31 | $0.86B | $0.12B | 14.17% |
| 2021-12-31 | $0.77B | $0.12B | 15.12% |
| 2021-09-30 | $0.76B | $0.14B | 18.65% |
| 2021-06-30 | $0.71B | $0.13B | 17.63% |
| 2021-03-31 | $0.70B | $0.12B | 16.76% |
| 2020-12-31 | $0.69B | $0.10B | 14.56% |
| 2020-09-30 | $0.69B | $0.09B | 12.34% |
| 2020-06-30 | $0.67B | $0.06B | 9.02% |
| 2020-03-31 | $0.63B | $0.06B | 9.68% |
| 2019-12-31 | $0.56B | $0.05B | 9.45% |
| 2019-09-30 | $0.49B | $0.05B | 9.61% |
| 2019-06-30 | $0.50B | $0.09B | 18.20% |
| 2019-03-31 | $0.49B | $0.08B | 17.04% |
| 2018-12-31 | $0.52B | $0.11B | 21.31% |
| 2018-09-30 | $0.53B | $0.13B | 23.97% |
| 2018-06-30 | $0.46B | $0.09B | 20.04% |
| 2018-03-31 | $0.42B | $0.09B | 21.33% |
| 2017-12-31 | $0.38B | $0.08B | 21.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |